This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BALA CYNWYD, Pa.,
May 6, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential shareholder claims against Accretive Healthcare, Inc. ("Accretive" or the "Company") (NYSE: AH) in connection with possible violations of federal securities laws.
At all relevant times Accretive reported strong financial and operational results to investors. However, on
February 26, 2013 the Company announced that it would postpone the release of its financial results because it was evaluating the timing of revenue recognition. On this news, shares of Accretive stock fell
$2.54 per share, to close on
February 27, 2013 at
$9.57 per share. Then on
March 8, 2013 the Company disclosed that the timing of revenue recognition under certain managed service contracts was incorrect. As a result, Accretive announced that it would restate its financial statements for the years 2010, 2011, and parts of 2012. The investigation concerns possible breaches of fiduciary duty and other violations of both federal and state law.
If you purchased shares of Accretive between
May 20, 2010 and
February 26, 2013 and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602,
Bala Cynwyd, PA 19004, visiting
http://brodsky-smith.com/581-ah-accretive-healthcare-inc.html, by e-mail at
firstname.lastname@example.org, by calling toll free 877-LEGAL-90.
Attorney advertising. Prior results do not guarantee a similar outcome.